No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 |
Autologous umbilical cord blood |
- |
- |
- |
- |
[2] 211, 294 |
2 |
Bronchodilator response |
- |
- |
- |
- |
[1] 294 |
3 |
Hypersaline |
- |
- |
- |
- |
[1] 294 |
4 |
Inomax 800ppm mol/mol inhalatiegas |
Nitric oxide |
D00074 |
- |
- |
[1] 294 |
5 |
Milrinone |
Milrinone |
D00417, D02085 |
[2] PDE3A, PDE3B |
[11] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
[1] 294 |
6 |
Neophyr 1000ppm mol/mol |
- |
- |
- |
- |
[1] 294 |
7 |
Nitric oxide |
Nitric oxide |
D00074 |
- |
- |
[7] 46, 85, 86, 98, 251, 294, 299 |
8 |
Omeprazole |
Omeprazole |
D00455, D01207, D05259, D05261 |
[2] ATP4A, ATP4B |
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
9 |
Omeprazole rectally 1mg/kg |
Omeprazole |
D00455, D01207, D05259, D05261 |
[2] ATP4A, ATP4B |
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
[1] 294 |
10 |
Probiotic treatment |
- |
- |
- |
- |
[1] 294 |
11 |
Revatio 0.8mg/ml solution for injection |
- |
- |
- |
- |
[1] 294 |
12 |
Sildenafil |
Sildenafil |
D02229, D08514 |
[1] PDE5A |
[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
[15] 6, 46, 50, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 |